To introduce the otolaryngology community to the current state of research regarding electronic cigarettes, with special attention paid to mechanism, impact on health and addiction, and use in smoking cessation.
Data Sources
Review of Google Scholar and PubMed databases using the keywords electronic cigarettes, e-cigs, e-cigarettes, and vaping. In addition, information from media sources as well as news outlets was evaluated to gauge public perception of research findings.
Review Methods
Recent research and randomized controlled trials were prioritized.
Conclusions
The landscape of electronic cigarette devices is evolving, as is the research regarding their risks and benefits. Utilization is rapidly increasing. It appears that older users employ them as a smoking cessation tool compared to younger users. The data are generally inconclusive regarding the benefits of electronic cigarettes for smoking cessation compared with other methods. Furthermore, the safety profile of electronic cigarettes is dynamic and difficult to fully ascertain.
Implications for Practice
Patients with a variety of otolaryngologic conditions, including cancer, may benefit from frank discussion regarding electronic cigarettes. Furthermore, increasing patient inquiries regarding these devices are likely given their increasing popularity.
FouldsJVeldheerSBergA. Electronic cigarettes (e-cigs): views of aficionados and clinical/public health perspectives. Int J Clin Pract. 2011;65:1037-1042.
2.
ZhuSHSunJYBonnevieE. Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control. 2014;23(suppl 3):iii3-9.
ReganAKPromoffGDubeSR. Electronic nicotine delivery systems: adult use and awareness of the ‘e-cigarette’ in the USA. Tob Control. 2013;22:19-23.
6.
ZhuSHGamstALeeM. The use and perception of electronic cigarettes and snus among the U.S. population. PLoS One. 2013;8:e79332.
7.
PepperJKEmerySLRibislKM. How U.S. adults find out about electronic cigarettes: implications for public health messages. Nicotine Tob Res. 2014;16:1140-1144.
8.
BunnellREAgakuITArrazolaR. Intentions to smoke cigarettes among never-smoking U.S. middle and high school electronic cigarette users, National Youth Tobacco Survey, 2011-2013. Nicotine Tob Res. 2015;17(2):228-235.
9.
BrodyJS. The promise and problems of e-cigarettes. Am J Respir Crit Care Med. 2014;189:379-380.
10.
DawkinsLCorcoranO. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology. 2014;231:401-407.
GoniewiczMLHajekPMcRobbieH. Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: regulatory implications. Addiction. 2014;109:500-507.
14.
FarsalinosKEPolosaR. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf. 2014;5:67-86.
15.
GoniewiczMLKnysakJGawronM. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23:133-139.
BurstynI. Peering through the mist: systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks. BMC Public Health. 2014;14:18.
18.
McMillenRMadukaJWinickoffJ. Use of emerging tobacco products in the United States. J Environ Public Health. 2012;2012:989474.
19.
KingBAAlamSPromoffG. Awareness and ever-use of electronic cigarettes among U.S. adults, 2010-2011. Nicotine Tob Res. 2013;15:1623-1627.
EtterJFBullenC. A longitudinal study of electronic cigarette users. Addic Behav. 2014;39:491-494.
25.
DawkinsLTurnerJRobertsA. ‘Vaping’ profiles and preferences: an online survey of electronic cigarette users. Addiction. 2013;108:1115-1125.
26.
VansickelARCobbCOWeaverMF. A clinical laboratory model for evaluating the acute effects of electronic “cigarettes”: nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev. 2010;19:1945-1953.
27.
BullenCHoweCLaugesenM. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382:1629-1637.
28.
CaponnettoPCampagnaDCibellaF. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013;8:e66317.
29.
SiegelMBTanwarKLWoodKS. Electronic cigarettes as a smoking-cessation: tool results from an online survey. Am J Prev Med. 2011;40:472-475.
30.
PolosaRCaponnettoPMorjariaJB. Effect of an electronic nicotine delivery device (e-cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health. 2011;11:786.
31.
HajekPEtterJFBenowitzN. Electronic cigarettes for smoking cessation. Lancet. 2013;382:1614-1616.
32.
DutraLMGlantzSA. Electronic cigarettes and conventional cigarette use among US adolescents: a cross-sectional study. JAMA Pediatr. 2014;168:610-617.
33.
CahnZSiegelM. Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes?J Public Health Policy. 2011;32:16-31.
KimHJShinHS. Determination of tobacco-specific nitrosamines in replacement liquids of electronic cigarettes by liquid chromatography–tandem mass spectrometry. J Chromatogr A. 2013;1291:48-55.
36.
WilliamsMVillarrealABozhilovK. Metal and silicate particles including nanoparticles are present in electronic cigarette cartomizer fluid and aerosol. PLoS One. 2013:8:e57987.
37.
KosmiderLSobczakAFikM. Carbonyl compounds in electronic cigarette vapors-effects of nicotine solvent and battery output voltage. Nicotine Tob Res. 2014;10:1319-1326.
VardavasCAnagnostopoulosNKougiasM. Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest. 2012;141:1400-1406.
40.
FlourisADChortiMSPoulianitiKP. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol. 2013;25:91-101.
MayerB. How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century. Arch Toxicol. 2014;88:5-7.
KandelERKandelDB. A molecular basis for nicotine as a gateway drug. N Engl J Med. 2014;371:932-943.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
